Literature DB >> 9327784

Signal transduction through trimeric G proteins in megakaryoblastic cell lines.

H van der Vuurst1, G van Willigen, A van Spronsen, M Hendriks, J Donath, J W Akkerman.   

Abstract

The biogenesis of trimeric G proteins was investigated by measurement of the expression of alpha-subunits in the megakaryoblastic cell lines MEG-01, DAMI, and CHRF-288-11, representing stages of increasing maturation, and compared with platelets. Megakaryoblasts and platelets contained approximately equal amounts of Gi alpha-1/2, Gi alpha-3, Gq alpha, and G12 alpha protein. Maturation was accompanied by (1) downregulation of mRNA for Gs alpha and disappearance of iloprost-induced Ca2+ mobilization, (2) upregulation of the long form of Gs alpha protein (Gs alpha-L) and an increase in iloprost-induced cAMP formation, and (3) upregulation of G16 alpha mRNA and G16 alpha protein and appearance of thromboxane A2-induced signaling (Ca2+ mobilization and stimulation of prostaglandin I2-induced cAMP formation). Gz alpha protein was absent in the megakaryoblasts despite weak expression of Gz alpha mRNA in DAMI and relatively high levels of Gz alpha mRNA and Gz alpha protein in platelets. These findings reveal major changes in G protein-mediated signal transduction during megakaryocytopoiesis and indicate that G16 alpha couples the thromboxane receptor to phospholipase C beta.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327784     DOI: 10.1161/01.atv.17.9.1830

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  The effects of the statins lovastatin and cerivastatin on signalling by the prostanoid IP-receptor.

Authors:  O A Lawler; S M Miggin; B T Kinsella
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) impairs the regulation of apoptosis in megakaryocytes by activating NF-κB: a proteomic study.

Authors:  Michela Di Michele; Karen Peeters; Serena Loyen; Chantel Thys; Etienne Waelkens; Lutgart Overbergh; Marc Hoylaerts; Christel Van Geet; Kathleen Freson
Journal:  Mol Cell Proteomics       Date:  2011-10-04       Impact factor: 5.911

3.  Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors.

Authors:  M T Walsh; B T Kinsella
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

4.  Induction of insulin resistance by the adipokines resistin, leptin, plasminogen activator inhibitor-1 and retinol binding protein 4 in human megakaryocytes.

Authors:  Anja J Gerrits; Eelo Gitz; Cornelis A Koekman; Frank L Visseren; Timon W van Haeften; Jan Willem N Akkerman
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

5.  Co-expression of the collagen receptors leukocyte-associated immunoglobulin-like receptor-1 and glycoprotein VI on a subset of megakaryoblasts.

Authors:  Tessa A M Steevels; Geertje H A Westerlaken; Marloes R Tijssen; Paul J Coffer; Peter J Lenting; Jan Willem N Akkerman; Linde Meyaard
Journal:  Haematologica       Date:  2010-08-16       Impact factor: 9.941

6.  EP1- and FP-mediated cross-desensitization of the alpha (alpha) and beta (beta) isoforms of the human thromboxane A2 receptor.

Authors:  Leanne P Kelley-Hickie; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

7.  Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.

Authors:  Helen M Reid; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

8.  GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques.

Authors:  Anna L Khandoga; Dharmendra Pandey; Ulrich Welsch; Richard Brandl; Wolfgang Siess
Journal:  Cardiovasc Res       Date:  2010-11-23       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.